Industri

Exegenesis Bio and Modalis sign research deal for Duche...

The agreement involves the use of Modalis’ CRISPR-GNDM (Guide Nucleotide-Directe...

ABEC to expand global manufacturing network with new Wi...

A ribbon-cutting ceremony to mark the opening is scheduled for 24 September, wit...

Glenmark launches RYALTRIS nasal spray in Brazil for al...

The launch follows ANVISA approval and introduces an olopatadine-containing int...

The next injectable pharma race will be won on reliabil...

The injectable pharma landscape is becoming increasingly interconnected, with p...

HAB Pharma appoints Pankaj Agarwal as Chief Financial O...

The appointment comes as the company strengthens its financial and organisation...

Banner Ironwood Breaks Ground on 32,000-square-foot Exp...

Banner Ironwood Medical Center has broken ground on an expansion that will add m...

OPPI appoints Amitabh Dube as its President

The Organisation of Pharmaceutical Producers of India (OPPI), which represents ...

Solstice Oncology secures $225m to drive porustobart’s ...

The financing was raised in a Series A round led by RA Capital Management, with ...

TwoStep Therapeutics secures $62.5m funding to advance ...

Insight Partners and Medical Excellence Capital led the round, with additional i...

High Commissioner highlights stronger pharma partnershi...

Sri Lanka’s High Commissioner to India Mahishini Colonne highlighted opportunit...

FOPE seeks transition period, clarity on new FDC warnin...

The Federation of Pharma Entrepreneurs (FOPE) has sought clarification and a re...

Complex-molecule specialist Shilpa CDMO launches at CPH...

Shilpa CDMO, a dedicated complex small-molecule contract development and manufa...

UK-MHRA inspects Indoco’s solid dosages facility in Goa

Indoco Remedies announced that the UK Medicines and Healthcare Products Regulat...

Fredun Pharmaceuticals acquires Furlicks from pharma ma...

Fredun Pharmaceuticals Limited (FPL), has acquired Furlicks, an innovative pet-...

 MSD inaugurates Technology Centre in Hyderabad

MSD, a  global biopharmaceutical leader, inaugurated its new 2.5 lakh sq. ft Te...

How Capital Constraints Are Reshaping Healthcare Projec...

Healthcare capital has less room for error than it did a few years ago. Construc...